|
Sex Differences Meeting Planning Committee
|
Meeting/ Workshop
|
BARDA
|
NIAID, OD/DPCPSI/ORWH
|
Understanding sex differences within animal models is needed to develop effective biodosimeters and MCMs. Therefore, a meeting is planned to 1) explore sex differences in metabolomics and/or other biomarkers that may track with assessing acute radiation syndrome (ARS), delayed effects of acute radiation exposure (DEARE), and/or predicting the efficacy of MCMs; 2) look at effects of synchronizing estrocycle in pre-clinical studies, and pheromones when co-housing male and female animals; 3) explore regulatory challenges in clinical studies involving representation from both sexes and policies that influence inclusion of women in research, and the gaps that exist in these practices. Meeting to be held Oct 25-26, 2021.
|
|
SHIELD Standardization of Lab Data to Enhance Outcomes Research and Value Based Care (SHIELD)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, CDC
|
NLM
|
This project will expand the collaborative efforts of FDA and other stakeholders involved in the SHIELD initiative to ensure laboratory information interoperability, such that the same type of device is described the same way in electronic health records (EHR) systems. To realize this goal, this project will develop code mapping manuals to consistently map the same LOINC (Logical Observations Identifiers Names and Codes) to the same type of IVD. This is important because without the specific guidance, manufacturers of IVD devices and laboratories often assign different (and frequently incorrect) LOINC codes for the same type of device. This project will also pilot implementation of SHIELD standard digital formats to update infrastructure in active healthcare provider laboratories, which will include the seamless distribution of LOINC and SNOMED-CT (Systematized Nomenclature of Medicine--Clinical Terms) coding to those provider institutions and registries.
|
|
Sickle Cell Disease Federal Interagency Work Group (SCD FIWG)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, CDC, HRSA, OASH
|
NHGRI, NHLBI
|
The Sickle Cell Disease Federal Interagency Work Group (FIWG) fosters a community of partners engaged in achieving the vision of long, healthy, productive lives for those living with Sickle Cell Disease (SCD) and those with Sickle Cell Trait (SCT)." This involves building the capacity to address the recommendations shared in the NASEM Sickle Cell Disease Strategic Plan and Blueprint for action.
|
|
Smokefree.gov Initiative
|
Resource Development
|
CDC, FDA, IHS
|
NCI, NIMHD
|
TheSmokefree.govInitiative (SFGI)provides tobacco users who want to quit with free, evidence-based cessation information and on-demand support. SFGI includes 6 mobile-optimized websites, 9 SMS text programs, 2 smartphone apps, and 6 social media platforms. Tailored content is provided for special populations including women, teens, Spanish speakers, veterans, and older adults.
|
|
Social Determinants of Health Interagency Policy Committee (SDOH-IPC)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, CDC, CMS, HRSA, SAMHSA, Other, ASPR
|
NINR
|
Convened by the White House Domestic Policy Council and the Office of Science and Technology Policy - the SDOH-IPC purpose is to support a Federal framework for a Coordinated Care Delivery Model to Address SDOH Develop a White House Action Plan sharing guidance and potential policy levers to address Social Determinants of Health through data accessibility, integration and blending and braiding of funds.
|
|
Social Determinants of Health Research Coordinating Committee (NIH SDOH RCC)
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA
|
NCI, NIMHD, NIA, NINR, NIEHS, NCATS, FIC, NIAMS, NCCIH, OD/DPCPSI/ORWH, OD/DPCPSI/ODP, OD/DPCPSI/OBSSR
|
The overall goal of the Research Coordinating Committee (RCC) is to accelerate NIH-wide SDOH research across diseases and conditions, populations, stages of the life course, and SDOH domains, domestically and globally.
|
|
Society for Prevention Research Annual Conference (SPR)
|
Meeting/ Workshop
|
CDC, ACF
|
NIAAA, NCCIH, NCI, NIDA
|
This annual conference is funded by an R13 award and is co-funded by several other NIH Institutes as well as the ACF and the CDC.
|
|
Somatic Cell Genome Editing
|
Research Initiative
|
FDA
|
OD/DPCPSI/OSC, NCATS, NCI, NHGRI, NHLBI, NIAID, NIAMS, NIDDK, NIMH, NINDS, OD/DPCPSI/ORIP, NIBIB, NEI, NICHD, NIDA, NIEHS
|
The Somatic Cell Genome Editing (SCGE) program aims to develop quality tools to perform effective and safe genome editing in human patients. These research tools will be made widely available to the research community to reduce the time and cost required to develop new therapies. A representative from Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) plays an advisory role for the program regarding regulatory issues. The SCGE program is a member of the National Institute of Standards and Technology (NIST) Gene Editing Consortium. The SCGE program also coordinates with the DARPA Safe Genes program when appropriate.
|
|
Special Populations Research Forum, Clinical Research Recommendations Subcommittee (SPRF-CRRC)
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA
|
NCI, NINDS, NHLBI, OD/DPCPSI/SGMRO, OD/AoU
|
The Special Populations Research Forum (SPRF) provides a resource for NIH and HHS staff to share best practices and lessons learned in promoting diversity, equity, and inclusion (DEI) in intramural and extramural training and research.
|
|
State Cancer Profiles
|
Resource Development
|
CDC
|
NCI
|
State Cancer Profiles is an interactive mapping engine produced in collaboration between the National Cancer Institute and Centers for Disease Control and Prevention. It was developed with the idea to provide a geographic profile of cancer burden in the United States and reveal geographic disparities in cancer incidence, mortality, risk factors for cancer, and cancer screening across different population subgroups. The target audiences are health planners, policy makers, and cancer information providers who need quick and easy access to cancer related data and maps to inform and prioritize investments in cancer control.
|